Inflammatory markers in a 2-year soy intervention among premenopausal women

Journal of Inflammation

Table 1 Characteristics of study participants in a 2-year soy trial

Variable	Controls	Intervention	P-value²
	Mean [SD]	Mean [SD]
Number obf subjects	93	90
Age at randomization (y)	42.7 [3.0]	43.3 [2.9]	0.21
Ethnicity¹
Caucasian	35 [37.6%]	32 [35.6%]	0.96
Japanese	24 [25.8%]	25 [27.8%]
Hawaiian	11 [11.8%]	12 [13.3%]
Filipino	7 [7.5%]	4 [4.4%]
Chinese	7 [7.5%]	7 [7.8%]
Mixed/other	9 [9.6%]	10 [11.3%]
Body weight (kg)
At baseline	68.3 [17.5]	67.9 [15.2]	0.87
After 2 y	69.1 [16.1]	69.1 [15.5]	0.99
Change over 2 y	0.8 [4.1]	1.2 [3.6]	0.54
Body mass index (kg/m²)
At baseline	26.1 [6.1]	26.2 [5.4]	0.96
After 2 y	26.4 [6.5]	26.6 [5.5]	0.85
Change over 2 y	0.32 [1.5]	0.45 [1.4]	0.54
Lifetime soy intake (svgs)	2440 [2967]	2044 [2541]	0.33
Soy consumption (svgs/y)¹
During early life >0	49 [52.7%]	47 [52.2%]	0.95
During adult life >36	47 [50.5%]	45 [50.0%]	0.94
Lifetime ≥ 27	49 [52.7%]	47 [52.2%]	0.95
Marker levels at baseline
CRP (mg/L)	2.31 [3.28]	1.95 [3.10]	0.44
IL-6 (pg/mL)	1.36 [1.47]	1.06 [0.64]	0.08
Adiponectin (μg/mL)	8.13 [3.68]	7.87 [4.13]	0.65
Leptin (ng/mL)	19.06 [15.78]	19.45 [15.02]	0.87

ISSN: 1476-9255